Danielle Antalffy
Stock Analyst at UBS
(3.56)
# 907
Out of 4,914 analysts
169
Total ratings
50%
Success rate
5.64%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $130 → $135 | $106.41 | +26.87% | 13 | Jul 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $547 → $585 | $500.79 | +16.82% | 2 | Jul 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $180 → $190 | $168.33 | +12.87% | 5 | Jul 17, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $10 → $8.6 | $5.71 | +50.61% | 6 | May 9, 2025 | |
| ATRC AtriCure | Maintains: Buy | $60 → $58 | $36.97 | +56.88% | 13 | Apr 30, 2025 | |
| INMD InMode | Maintains: Neutral | $19 → $16 | $14.26 | +13.96% | 4 | Apr 29, 2025 | |
| RXST RxSight | Downgrades: Neutral | $45 → $16 | $7.86 | +103.56% | 3 | Apr 9, 2025 | |
| MDT Medtronic | Maintains: Neutral | $85 → $95 | $92.10 | +3.15% | 10 | Feb 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5.5 → $5 | $3.50 | +42.86% | 2 | Jan 27, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $146 → $148 | $128.74 | +14.96% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $182 | $95.06 | +91.46% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $401.32 | -7.80% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $81.38 | -7.84% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $112 → $107 | $94.76 | +12.92% | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $95 | $89.82 | +5.77% | 8 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $27.08 | +176.96% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $405 → $322 | $130.15 | +147.41% | 5 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $1.87 | +20.32% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $28.70 | +49.83% | 5 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $16.73 | +169.06% | 14 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $280 | $299.08 | -6.38% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $17.59 | +4,590.16% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $13.45 | +4.09% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $71.74 | +39.40% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $8.96 | +33.93% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $52.93 | -43.32% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $40.52 | +11.06% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $182.07 | +51.04% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.81 | +315.80% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $6.70 | +526.87% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $3 | $0.50 | +494.77% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.93 | +1,506.00% | 1 | Sep 1, 2020 |
Boston Scientific
Jul 24, 2025
Maintains: Buy
Price Target: $130 → $135
Current: $106.41
Upside: +26.87%
Intuitive Surgical
Jul 23, 2025
Maintains: Neutral
Price Target: $547 → $585
Current: $500.79
Upside: +16.82%
Johnson & Johnson
Jul 17, 2025
Maintains: Buy
Price Target: $180 → $190
Current: $168.33
Upside: +12.87%
Treace Medical Concepts
May 9, 2025
Maintains: Neutral
Price Target: $10 → $8.6
Current: $5.71
Upside: +50.61%
AtriCure
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $36.97
Upside: +56.88%
InMode
Apr 29, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $14.26
Upside: +13.96%
RxSight
Apr 9, 2025
Downgrades: Neutral
Price Target: $45 → $16
Current: $7.86
Upside: +103.56%
Medtronic
Feb 19, 2025
Maintains: Neutral
Price Target: $85 → $95
Current: $92.10
Upside: +3.15%
Sight Sciences
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $3.50
Upside: +42.86%
Abbott Laboratories
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $128.74
Upside: +14.96%
Dec 6, 2024
Initiates: Buy
Price Target: $182
Current: $95.06
Upside: +91.46%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $401.32
Upside: -7.80%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $81.38
Upside: -7.84%
Aug 8, 2024
Maintains: Sell
Price Target: $112 → $107
Current: $94.76
Upside: +12.92%
Jul 26, 2024
Maintains: Buy
Price Target: $163 → $95
Current: $89.82
Upside: +5.77%
Jan 22, 2024
Initiates: Buy
Price Target: $75
Current: $27.08
Upside: +176.96%
Sep 6, 2023
Maintains: Buy
Price Target: $405 → $322
Current: $130.15
Upside: +147.41%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $1.87
Upside: +20.32%
Mar 29, 2023
Initiates: Neutral
Price Target: $43
Current: $28.70
Upside: +49.83%
Mar 29, 2023
Initiates: Neutral
Price Target: $45
Current: $16.73
Upside: +169.06%
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $299.08
Upside: -6.38%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $17.59
Upside: +4,590.16%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $13.45
Upside: +4.09%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $71.74
Upside: +39.40%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $8.96
Upside: +33.93%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $52.93
Upside: -43.32%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $40.52
Upside: +11.06%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $182.07
Upside: +51.04%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.81
Upside: +315.80%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $6.70
Upside: +526.87%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $3
Current: $0.50
Upside: +494.77%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.93
Upside: +1,506.00%